paper-with-me

홈 › Papers

Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma

2021-12-23 · Front Immunol. 2021 12 · Chenjie Qiu, 1, † Wenxiang Shi, 2, † Huili Wu, 3, † Shenshan Zou, 1 Jianchao Li, 1 Dong Wang, 1 Guangli Liu, 1 Zhenbiao Song, 1 Xintao Xu, 1 Jiandong Hu, corresponding author 1, * and Hui Gengcorresponding author 1, *

Both tumour-infiltrating immune cells and inflammation-related genes that can mediate immune infiltration contribute to the initiation and prognosis of patients with colon cancer. In this study, we developed a method to predict the survival outcomes among colon cancer patients and direct immunotherapy and chemotherapy. We obtained patient data from The Cancer Genome Atlas (TCGA) and captured inflammation-related genes from the GeneCards database. The package “ConsensusClusterPlus” was used to generate molecular subtypes based on inflammation-related genes obtained by differential expression analysis and univariate Cox analysis. A prognostic signature including four genes (PLCG2, TIMP1, BDNF and IL13) was also constructed and was an independent prognostic factor. Cluster 2 and higher risk scores meant worse overall survival and higher expression of human leukocyte antigen and immune checkpoints. Immune cell infiltration calculated by the estimate, CIBERSORT, TIMER, ssGSEA algorithms, tumour immune dysfunction and exclusion (TIDE), and tumour stemness indices (TSIs) were also compared on the basis of inflammation-related molecular subtypes and the risk signature. In addition, analyses of stratification, somatic mutation, nomogram construction, chemotherapeutic response prediction and small-molecule drug prediction were performed based on the risk signature. We finally used qRT–PCR to detect the expression levels of four genes in colon cancer cell lines and obtained results consistent with the prediction. Our findings demonstrated a four-gene prognostic signature that could be useful for prognostication in colon cancer patients and designing personalized treatments, which could provide new versions of personalized management for these patients.

📄 PDF Abstract BibTeX

Code (0)

등록된 구현이 없습니다.

Tasks

Prognosis

Similar Papers 제목 키워드 기반

Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep Learning

2026-01-06 · Abdul Rehman Akbar, Alejandro Levya, Ashwini Esnakula, Elshad Hasanov 외 arxiv

Molecular subtyping of PDAC into basal-like and classical has established prognostic and predictive value. However, its use in clinical practice is limited by cost, turnaround time, and tissue requirements, thereby restr…

Representation Learning

An evaluation of DNA-damage response and cell-cycle pathways for breast cancer classification

2015-05-19

Accurate subtyping or classification of breast cancer is important for ensuring proper treatment of patients and also for understanding the molecular mechanisms driving this disease. While there have been several gene si…

Cancer Classificationfeature selectionPrognosis

MulMarker: a comprehensive framework for identifying multi-gene prognostic signatures

2023-08-22 · Xu Zhang, Lei Chen

Prognostic signatures play an important role in clinical research, offering insights into the potential health outcomes of patients and guiding therapeutic decisions. Although single-gene prognostic biomarkers are valuab…

Chatbot

Biologic and Prognostic Feature Scores from Whole-Slide Histology Images Using Deep Learning

2019-10-21 · Okyaz Eminaga, Mahmood Abbas, Yuri Tolkach, Rosalie Nolley 외

Histopathology is a reflection of the molecular changes and provides prognostic phenotypes representing the disease progression. In this study, we introduced feature scores generated from hematoxylin and eosin histology …

One-dimensional convolutional neural network model for breast cancer subtypes classification and biochemical content evaluation using micro-FTIR hyperspectral images

2023-10-23 · Matheus del-Valle, Emerson Soares Bernardes, Denise Maria Zezell

Breast cancer treatment still remains a challenge, where molecular subtypes classification plays a crucial role in selecting appropriate and specific therapy. The four subtypes are Luminal A (LA), Luminal B (LB), HER2 su…